EFFECTIVE CLUSTERING OF IMMUNOLOGICAL ENTITIES

(19)

(11)

EP 3 767 629 A8

(12)	CORRECTED EUROPEAN PATENT APPLICATION
	published in accordance with Art. 153(4) EPC

(15)	Correction information:
	Corrected version no 1 (W1 A1)

(48)	Corrigendum issued on:
	28.04.2021 Bulletin 2021/17

(43)	Date of publication:
	20.01.2021 Bulletin 2021/03

(21)	Application number: 19767188.6

(22)	Date of filing: 15.03.2019

(51)

International Patent Classification (IPC):

G16B 40/00^(2019.01)
A61K 39/395^(2006.01)
G01N 33/53^(2006.01)

A61K 39/00^(2006.01)
A61P 37/02^(2006.01)
G16B 15/30^(2019.01)

(86)	International application number:
	PCT/JP2019/010861

(87)	International publication number:
	WO 2019/177152 (19.09.2019 Gazette 2019/38)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

16.03.2018 JP 2018049440

(71)	Applicant: KOTAI Biotechnologies, Inc.
	Suita-shi Osaka 565-0871 (JP)

(72)	Inventors:
	YAMASHITA Kazuo Suita-shi, Osaka 565-0871 (JP) BILLAUD, Joel Kasuga-shi, Fukuoka 816-0844 (JP) SAX Nicolas Claude Paul Suita-shi, Osaka 565-0871 (JP)

(74)	Representative: Uexküll & Stolberg
	Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstraße 4 22607 Hamburg 22607 Hamburg (DE)

(54)	EFFECTIVE CLUSTERING OF IMMUNOLOGICAL ENTITIES

(57) The present invention provides a method for classifying immunological entities. The inventors assume that there are commonalities among antigen specificities for which, without a function being specified in advance, bound immunological entities (antigens, epitopes, etc.) are normally handled individually as separate "functions (for example, whether antigen A has the specificity)," and the inventors have discovered that it is possible to classify immunological entities by evaluating the similarities thereof. This method has a high degree of precision with respect to immunity-related illnesses, and the present invention is clinically applicable.